menu
    • menu

    Company profile for EyeBio

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    EyeBio is a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to protect, restore, and improve vision in patients with sight-threatening eye diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EyeBiounitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    International Building 71 Kingsway London WC2B 6ST England
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://eyebiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/eyebio/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Merck and EyeBio Initiate Phase 2b/3 Trial for Diabetic Macular Edema
    Merck and EyeBio Initiate Phase 2b/3 Trial for Diabetic Macular Edema

    04 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240904993839/en

    BUSINESSWIRE
    04 Sep 2024
    Share Share
    Merck Completes Acquisition of EyeBio
    Merck Completes Acquisition of EyeBio

    12 Jul 2024

    // PRESS RELEASE

    https://www.merck.com/news/merck-completes-acquisition-of-eyebio/

    PRESS RELEASE
    12 Jul 2024
    Share Share
    Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports
    Merck nears $1.3 bln cash deal for eye-drug company EyeBio, WSJ reports

    29 May 2024

    // REUTERS

    https://www.reuters.com/markets/deals/merck-nears-13-bln-cash-deal-eye-drug-company-eyebio-wsj-reports-2024-05-29/

    REUTERS
    29 May 2024
    Share Share
    Merck to Acquire EyeBio
    Merck to Acquire EyeBio

    29 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240529808692/en

    BUSINESSWIRE
    29 May 2024
    Share Share
    EyeBio targets registrational trial after early success of Wnt agonist
    EyeBio targets registrational trial after early success of Wnt agonist

    13 Feb 2024

    // Ayisha Sharma ENDPTS

    https://endpts.com/eyebio-targets-registrational-trial-after-early-success-of-wnt-agonist-in-retinal-diseases/

    Ayisha Sharma ENDPTS
    13 Feb 2024
    Share Share
    EyeBio Announces Expansion of Series A to $130 Million
    EyeBio Announces Expansion of Series A to $130 Million

    14 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231114783813/en

    BUSINESSWIRE
    14 Nov 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search